Oncological outcomes depend to a significant degree on the quality of surgery, which can be evaluated by pathologists through the integrity of the mesorectum, circumferential resection margin and lymph node yield. Learn with Mariana Berho how to maximize your knowledge in these areas.
Steven D. Wexner will answer this important question. The evaluation of the most important trials and publications allows us to examine the evidence in terms of morbidity, recurrence and survival. This presentation encourages us to persevere with minimally invasive surgery and new technologies.
During the AIS Summer Event 2016, we will be discussing how to improve outcomes in colorectal surgery. The top experts in this area will show us the evidence for the most important subjects in rectal cancer.
Finally, Richard J. Heald and Antonio M. Lacy thanked all the participants in this wonderful event, remembering the recently deceased Professor Lars Påhlman. Thank you, Lars!
In the final section, Steven D. Wexner focused on all the aspects examined during the congress, analysing them point per point.
In this section we focused on the pathology audit after rectal cancer resection. Questions as the following were discussed: Why is it so important that systematic evaluation of the surgical specimen should be translated into a universal language? How can the limits of a correct oncological resection be defined? How can lymph node mapping be improved?
After surgical resection, some patients must receive adjuvant therapy. Jaume Capdevila discussed one of the hottest controversies in the field. Should the decision to receive adjuvant therapy be made on the basis of the initial staging or on the basis of tumor response?
There is a group of rectal cancer patients who have specific genetic mutations that require modified surveillance strategies. Francesc Balaguer explained, among other aspects, who these patients are and what should be done.
Continuos evaluation of several issues related to oncological resection for rectal cancer, combined with the evolution of technology have led to the Cecil Approach. The Cecil Approach involves simultaneous work by a transabdominal and by a transanal team to deliver the best results for rectal cancer patients. Antonio M. Lacy, Salvadora Delgado & María F. Hevia performed this innovative technique […]
Selected rectal cancer patients are submitted to pre-operative therapies that seek to obtain several benefits such as lesion downsizing and downstaging, improving the quality of the surgical resection. However, some patients develop side effects. It is obviously clear that that the balance between risks and benefits should always fall on the patient’s side.
Several studies are required to diagnose rectal cancer. Each of them provides information required to characterise the disease for later treatment customisation. Steven D. Wexner led the first section of this Winter Event, which focused on the diagnosis and staging of rectal cancer.
AIS Channel Winter Event 2015 was broadcast from the Hospital Clinic of Barcelona – more specifically, from the Optimus Operating Theatre, a unique, cutting-edge surgical space that served as suitable stage for our guests. Richard J. Heald was in charge of introducing the event.